Table 2. Summary of MERS associated with SARS-CoV-2 infection in previously published reports.

F: female; M: male; MIS-C: multisystem inflammatory syndrome in children; MRI: magnetic resonance imaging; NR: not reported; PR: present report

Patient number	Reference	Age (years)	Sex	Neurological symptoms	Serum sodium (mEq/l)	Day of the first MRI (since the first neurological symptoms)	Day of follow-up MRI (since the first neurological symptoms)	Diagnosis	Outcome
1	Abdel-Mannan et al. [6]	15	F	Confused, disoriented, headache, weakness	Normal	5 days	NR	MIS-C	Recovering
2	Abdel-Mannan et al. [6]	15	F	Confused, dysarthria, dysphagia	Normal	21 days	NR	MIS-C	Day 32: still inpatient; encephalopathy resolved, wheelchair bound
3	Abdel-Mannan et al. [6]	9	M	Confused, ataxia, dysarthria, headache	129	1 day	6 days (with minimal signal changes remaining on T2)	MIS-C	Recovering
4	Varol et al. [7]	15	M	Headache, dizziness, blurred vision, agitation, vomiting	128	5 days	15days (disappeared)	MIS-C	Recovering
5	Varol et al. [7]	14	M	Ataxia, hallucinations	135	3 days	10days (disappeared)	MIS-C	Recovering
6	Bektaş et al. [8]	11	F	Personality changes	132	6 days	7 days (disappeared)	MIS-C	Recovering
7	Bektaş et al. [8]	10	M	Agitation, disorient, hallucinations	131	2 days	7 days (disappeared)	MIS-C	Recovering
8	Gaur et al. [9]	12	M	Lethargy, headache, vomiting	NR	5 days	Not performed	MIS-C	Recovering
9	Gaur et al. [9]	9	M	Altered mental state, lethargy, dysarthric, ataxic	NR	NR	NR (disappeared)	COVID-19	Recovering
10	PR	9	M	Vomiting, poor speech	133	2 days	9 days (disappeared)	COVID-19	Recovering